|
Volumn 22, Issue 12, 2000, Pages 1410-1420
|
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis
a b c d d d |
Author keywords
Acute exacerbation of chronic bronchitis; Clarithromycin; Extended release; Immediate release; Treatment
|
Indexed keywords
CLARITHROMYCIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
CHRONIC BRONCHITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
COUGHING;
DIARRHEA;
DISEASE EXACERBATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
PATIENT COMPLIANCE;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
TASTE DISORDER;
|
EID: 0034530303
PISSN: 01492918
EISSN: 1879114X
Source Type: Journal
DOI: 10.1016/S0149-2918(00)83040-4 Document Type: Article |
Times cited : (28)
|
References (18)
|